Nuwellis, Inc. current report, 28 March 2017

Business Context and Reporting Period

This Form 8-K is filed by Sunshine Heart, Inc. (not Nuwellis, Inc.) on March 28, 2017. The report addresses a Nasdaq listing extension and the completion of a warrant exercise agreement with institutional investors.

Key Financial Metrics

  • Cash Proceeds: Approximately $1,427,000 raised from warrant exercises between March 10, 2017, and March 28, 2017.
  • Shares Issued: 763,998 shares of common stock issued upon exercise.
  • Replacement Warrants: 763,998 replacement warrants issued with exercise prices ranging from $1.73 to $3.77 per share.
  • Listing Requirement: The company is working to meet the minimum $2.5 million stockholders' equity requirement for continued Nasdaq listing.
  • Other Metrics: The filing text does not provide clear values for revenue, profit, operating cash flow, margins, or total debt.

Material Changes

  • Warrant Status: As of March 28, 2017, the warrants held by the Investors under the February 15, 2017 agreement have been fully exercised. No further replacement warrants will be issued under this specific agreement.
  • Listing Status: The Nasdaq Hearings Panel granted an extension for continued listing through May 10, 2017, contingent on the company evidencing compliance with listing criteria.

Outlook, Risks, and Management Commentary

  • Compliance Efforts: Management states the company is "diligently working to timely satisfy the terms" of the Nasdaq Panel's decision regarding stockholders' equity.
  • Regulatory Risk: The company faces the risk of delisting if it fails to meet the $2.5 million stockholders' equity requirement by the May 10, 2017 deadline.
  • Unusual Items: The issuance of securities was conducted under exemptions provided by Rule 506 of Regulation D and Section 4(a)(2) of the Securities Act.

Investor Verification Checklist

  • Verify the company's current stockholders' equity to assess compliance with the $2.5 million Nasdaq requirement.
  • Confirm the exact number of outstanding replacement warrants and their specific exercise prices.
  • Monitor subsequent filings for updates on the May 10, 2017 listing deadline.
  • Note the discrepancy between the requested company name (Nuwellis, Inc.) and the actual registrant (Sunshine Heart, Inc.).